Pfizer's quarterly cash and cash equivalents
increased
from Jun. 2023 ($2,632.00 Mil) to Sep. 2023 ($3,148.00 Mil) but then
stayed the same
from Sep. 2023 ($3,148.00 Mil) to Dec. 2023 ($2,853.00 Mil).
Pfizer's annual cash and cash equivalents
declined
from Dec. 2021 ($1,944.00 Mil) to Dec. 2022 ($416.00 Mil) but then
increased
from Dec. 2022 ($416.00 Mil) to Dec. 2023 ($2,853.00 Mil).
Pfizer Cash And Cash Equivalents Historical Data
The historical data trend for Pfizer's Cash And Cash Equivalents can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Pfizer Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Cash And Cash Equivalents
1,121.00
1,786.00
1,944.00
416.00
2,853.00
Pfizer Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Cash And Cash Equivalents
416.00
2,166.00
2,632.00
3,148.00
2,853.00
Pfizer Cash And Cash Equivalents Calculation
Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.
Pfizer (NYSE:PFE) Cash And Cash Equivalents Explanation
A high number means either:
1) The company has competitive advantage generating lots of cash
2) Just sold a business or bonds (not necessarily good)
A low stockpile of cash usually means poor to mediocre economics.
There are 3 ways to create large cash reserve.
1) Sell new bonds or equity to public
2) Sell business or asset
3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)
When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.
Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.
Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.
Be Aware
Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.
Pfizer Cash And Cash Equivalents Related Terms
Thank you for viewing the detailed overview of Pfizer's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PFE has been successfully added to your 